Product Information
ACETAMINOPHEN 325 MG TABLET is a generic product labeled by Aarna USA Inc., priced at $0.0250 per EA under NDC 82568000102. Its NADAC has been published 22 times since Jan 28, 2026.
Strength
325 mg/1
Manufacturer
Aarna USA Inc.NDC
82568000102
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
5/15/2025
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 22 times since Jan 28, 2026, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0262 (Apr 15, 2026) |
| All-time low | $0.0250 (Jun 17, 2026) |
| 52-week high | $0.0262 |
| 52-week low | $0.0250 |
| Median price | $0.0261 |
| Average price | $0.0259 |
| Largest weekly change | -3.1% (May 20, 2026) |
| Weeks tracked | 22 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by Aarna USA Inc., is $0.0250 per EA (NDC 82568000102), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has declined 4.5%. It has been tracked across 22 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since Jan 28, 2026, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0250 (Jun 17, 2026) to a high of $0.0262 (Apr 15, 2026), with a median of $0.0261 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ACETAMINOPHEN 325 MG TABLET, is $0.0110 per EA — about 56% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 82568000102) is labeled by Aarna USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification